Trinity biotech subsidiary, primus corporation receives fda warning letter

Trinity biotech subsidiary, primus corporation receives fda warning letter.trinity biotech - primus corp got warning letter from fda following inspection of kansas city, missouri manufacturing facility that took place in jan. 2020.trinity biotech - issues identified in fda warning letter primarily relate to company's ultra2 product range.
TRIB Ratings Summary
TRIB Quant Ranking